Urologic Oncology Program
The Urologic Oncology Program offers patients access to emerging therapies through its research programs. Those programs include integrated clinical trials and a translational research lab that supports pre-clinical and clinical drug studies for cancers. In an ongoing effort to build one of the nation's leading research facilities, the program is staffed by high level research professionals. This team is on a campaign to find a cure for prostate cancer and collaborates with other leading specialists through the country. The program's team exchanges research and clinical insights to advance the fight against prostate cancer and, thanks to video conferencing, our physicians are able to communicate in real time with academic, scientific and clinical colleagues anywhere in the world, working as a virtual team.
Dr. Leland Chung and his team have developed a new method in predicting whether a prostate tumor will remain indolent or turn lethal. They are testing specific proteins or molecules, known as biomarkers, for their roles in how the cancer will turn.Read Full Story
Calypso Tumor Monitoring
A GPS-like monitoring system called Calypso, uses miniature implanted transponders to track prostate cancer in real time, providing precise, continuous information on the location of the tumor. This allows for greater accuracy in the delivery of radiation to the cancer while minimizing potential damage to healthy tissue.Read More